Nevertheless, they do not detract from the standardised conditions used to compare serum biomarker levels for patients within this study, from which we identified clinical support for pre-clinical studies that have previously postulated a role for the CCL5-CCR5 axis in the pathogenesis of pancreatic cancer. Here, CCR5 is linked to pancreatic neoplasm.